Application 022377
- Type
- NDA
- Sponsor
- MERIDIAN MEDCL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALSUMA | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022377-001 | ALSUMA | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Sportpharm LLC | 7d3602a1-1cd5-41c2-a0a3-3d20e90a92fa | 2026-07-09 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| sumatriptan succinate | SUMATRIPTAN SUCCINATE | Sun Pharmaceutical Industries, Inc. | 9485cc30-15e8-4b53-876d-db317145474b | 2026-06-25 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | REMEDYREPACK INC. | 73c9ac06-b55e-41e0-90ec-deb250f37eb5 | 2026-05-19 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Aurobindo Pharma Limited | b2503fff-c978-4efa-b1b4-d7740b6b26f2 | 2026-05-12 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Sportpharm LLC | d071aef6-a5bd-4f68-ba6d-03004466897c | 2026-04-24 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Golden State Medical Supply, Inc. | 1bf70380-8272-4c0d-8841-d39ef2772351 | 2026-04-15 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Dr. Reddy's Laboratories Limited | ac80d018-6abf-2e41-ddea-90b4ff9e9013 | 2026-03-21 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | A-S Medication Solutions | 62ba6fef-467a-4500-993c-51907f12a67c | 2026-02-14 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NorthStar Rx LLC | 84bfc4ba-4172-4adb-b963-4e0eb438c07a | 2026-02-13 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | Alembic Pharmaceuticals Inc. | 0e8b65f7-9d3b-42f2-8d7e-69b143365980 | 2026-01-29 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Dr. Reddys Laboratories Inc., | 8fef1176-7a38-eca3-22ca-83efe5ca6620 | 2026-01-21 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| ZEMBRACE SYMTOUCH | SUMATRIPTAN SUCCINATE | Upsher-Smith laboratories, LLC | 6e5b104f-2b9e-416e-92fb-ef1bdaea867d | 2026-01-09 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Sun Pharmaceutical Industries, Inc. | f235152e-dd8d-4679-9d9f-404fe5ff4fba | 2026-01-08 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Mylan Pharmaceuticals Inc. | 1d2cd01c-05e7-44cf-a71d-0f474e826b7e | 2026-01-01 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | Alembic Pharmaceuticals Limited | 16b7e44d-afa0-4177-80ef-c3ae9a78a4e1 | 2025-11-17 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Preferred Pharmaceuticals, Inc. | f2e7d756-1e12-462a-a43f-a9d860b11ee8 | 2025-09-25 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Preferred Pharmaceuticals, Inc. | bf9fd9fe-095b-4478-bd2e-a5534af07761 | 2025-09-25 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Preferred Pharmaceuticals Inc. | baf37e8c-d414-4ca7-a366-97dc202372ff | 2025-09-25 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Zembrace SymTouch | SUMATRIPTAN SUCCINATE | Tonix Medicines, Inc. | 3eb49807-fa9d-4a0d-9a3c-76de5b23b01b | 2025-02-28 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals, Inc. | 2efd4269-5657-9669-e063-6394a90a583a | 2025-02-25 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |